Improvement of reproductive performance in crossbred zebu anestrous primiparous cows by treatment with norgestomet implants or 96 h calf removal.
The aim of the present study was to compare the effect of norgestomet implants (NI) and calf removal (CR) for 96 h on estrus induction and first service fertility in crossbred zebu primiparous anestrous cows after 120 days postpartum. A total of 152 cows in a tropical environment were allotted to three experimental groups: CR for 96 h (n = 51), NI for 9 days plus 500 IU of PMSG at implant removal (n = 51) and a control group (CG) without treatment (n = 50). Estrous rate (%) and mean interval to first estrus (days) were 50.9 and 26.3+/-6.8; 60.7 and 13.8+/-6.8; 16.0% and 61.8+/-5.9 days for groups CR, NI and CG, respectively. CR and NI were statistically similar, however, both groups were different (P < 0.01) when compared with CG. Calving interval to first service and to conception were: CR: 151.2+/-8.4 and 157.8+/-21.4; NI: 145.2+/-8.5 and 150.9+/-21.3; CG: 186.8+/-7.3 and 201.0+/-18.5. A difference (P < 0.01) was found in both intervals when comparing the CR and NI with CG, with longer intervals for cows in the CG group. First service conception rates were 61.5, 67.7 and 62.5% for groups CR, NI and CG, respectively, and were not different (P > 0.05). These results demonstrate the efficacy of NI + PMSG or temporary CR for 96 h in inducing a fertile estrus and shortening the interval to estrus and to conception in primiparous crossbred anestrous zebu cows in the tropics.
Soto Belloso
E
E
Facultad de Ciencias Veterinarias, Universidad del Zulia, Maracaibo, Venezuela. eleazarsoto@cantv.net
Portillo Martínez
G
G
De Ondiz
A
A
Rojas
N
N
Soto Castillo
G
G
Ramírez Iglesia
L
L
Perea Ganchou
F
F
D000780:Anestrus; D000818:Animals; D002417:Cattle / Q000502:physiology*; D003433:Crosses, Genetic; D004343:Drug Implants; D004971:Estrus; D005260:Female; D007315:Insemination, Artificial / Q000662:veterinary; D007774:Lactation; D008297:Male; D010298:Parity; D049590:Postpartum Period; D011282:Pregnenediones / Q000008:administration & dosage*; D045167:Progesterone Congeners / Q000008:administration & dosage; D012098:Reproduction / Q000502:physiology*; D013997:Time Factors; D014886:Weaning
D004343:Drug Implants; D011282:Pregnenediones; D045167:Progesterone Congeners; C100284:norgestomet